Lumiracoxib
Product Specifications
CAS Number
220991-20-8
Target
COX
Related Pathways
Neuroscience, Immunology/Inflammation
Purity
0.9977
Bioactivity
Lumiracoxib (Prexige) is a novel, selective COX-2 inhibitor with IC50 and Ki of 0.14 μM and 0.06 μM, exhibits 515-fold selectivity over COX-1. Phase 4.
Smiles
N(C1=C(CC(O)=O)C=C(C)C=C1)C2=C(Cl)C=CC=C2F
Molecular Formula
C15H13ClFNO2
Molecular Weight
293.72
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Lsx8476-50gEcoli 50 µg (E. coli)
Recombinant Clostridium Botulinum rimP Protein (aa 1-153) (strain 657 / Type Ba4)
Sign In for Pricing
View Details 
GTR15268865 1 Vial
Lentiviral mouse Ephx3 shRNA (UAS) - Lentiviral mouse Ephx3 shRNA (UAS) (25)
Sign In for Pricing
View Details 
OR1076544-01 100 mg
4,4-Dimethyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -3,4-dihydroquinolin-2 (1H) -one
Sign In for Pricing
View Details 
OR1076544-02 250 mg
4,4-Dimethyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -3,4-dihydroquinolin-2 (1H) -one
Sign In for Pricing
View Details OR1076544-03 1 g
4,4-Dimethyl-8- (4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) -3,4-dihydroquinolin-2 (1H) -one
Sign In for Pricing
View Details